IMA ImageneBio, Inc.

Fundamentals / CIK 0001835579 / USD

ImageneBio, Inc. reported $800K in revenue and a net loss of $43.33M for the fiscal year ended December 31, 2025 (down 77.1% year over year), with a -6259.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open IMA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$37.80M$18.90M$0-$66.93MFY 2020 Revenue: $9.19MFY 2020 Net Income: -$44.26M2020FY 2021 Revenue: $30.98MFY 2021 Net Income: -$34.12M2021FY 2022 Revenue: $15.62MFY 2022 Net Income: -$68.77M2022FY 2023 Revenue: $9.16MFY 2023 Net Income: -$68.17M2023FY 2024 Revenue: $3.50MFY 2024 Net Income: -$36.57M2024FY 2025 Revenue: $800KFY 2025 Net Income: -$45.35M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $800K $3.50M $9.16M $15.62M $30.98M $9.19M
Research & Development $28.52M $32.11M $59.65M $64.32M $47.11M $44.85M
Total Operating Expenses $49.25M $40.50M $84.58M $86.52M $65.12M $53.71M
Operating Income -$48.45M -$37.00M -$75.42M -$70.90M -$34.14M -$44.52M
EBITDA -$48.05M -$35.90M -$74.40M -$70.15M -$33.59M -$44.22M
Interest Income -- -- $7.11M $2.15M $23K --
Income Before Tax -$45.70M -$36.55M -$68.33M -$68.77M -- --
Income Tax Expense -$350K $13K -$162K $0 $0 --
Net Income -$45.35M -$36.57M -$68.17M -$68.77M -$34.12M -$44.26M
Basic EPS -$192.80 -$442.00 -$32.60 -$38.00 -$24.40 -$320.00
Diluted EPS -$192.80 -$442.00 -$32.60 -$38.00 -$24.40 -$320.00
Basic Shares Outstanding 243.5K 59.7K 2.1M 1.8M 1.4M 138.3K
Diluted Shares Outstanding -- 2.4M 2.1M 1.8M 1.4M 138.3K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $800K --
Research & Development $11.27M $6.67M $5.96M $3.68M $15.16M $5.65M $4.04M $3.76M
Total Operating Expenses $17.31M $11.78M $12.08M $8.91M $26.19M $7.36M $6.79M $6.14M
Operating Income -$17.31M -$11.78M -$12.08M -$8.91M -$26.19M -$7.36M -$6.00M -$6.14M
EBITDA -$17.31M -$11.78M -$12.08M -$8.51M -$26.19M -$7.36M -$5.99M -$6.05M
Income Before Tax -$15.60M -$10.16M -$10.61M -$7.18M -$24.85M -$7.58M -$6.08M -$4.80M
Income Tax Expense $20K $16K $10K -$276K -$74K $15K $28K $13K
Net Income -$15.62M -$10.18M -$10.62M -$6.91M -$24.78M -$7.58M -$6.08M -$4.81M
Basic EPS -$0.91 -$0.63 -$0.95 -- -$2.91 -$4.46 -$3.80 --
Diluted EPS -$0.91 -$0.63 -$0.95 -- -$2.91 -$4.46 -$3.80 --
Basic Shares Outstanding 17.1M -- 11.2M -- 8.8M 2.4M 1.4M --
Diluted Shares Outstanding 17.1M 16.2M 11.2M -- 8.8M 2.4M 2.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $94.53M $12.12M $119.9M $59.92M $232.2M $162.5M
Short-Term Investments $40.82M $0 $55.57M $97.03M -- --
Cash & Short-Term Investments $135.3M $12.12M $175.5M $156.9M $232.2M $162.5M
Other Current Assets -- -- $1.15M $964K $629K $1.54M
Total Current Assets $140.3M $12.47M $178.7M $160.0M $236.5M $166.0M
Property, Plant & Equipment, Net $0 $8.0K $2.33M $3.21M $2.44M $1.39M
Other Non-Current Assets $4.88M $1.02M -- -- -- $872K
Total Non-Current Assets $12.69M $3.45M $13.43M $12.25M $11.36M $2.44M
Total Assets $153.0M $15.92M $192.1M $172.3M $247.9M $168.4M
Accounts Payable $1.44M $5.29M $2.07M $2.09M $2.38M $2.12M
Short-Term Debt $0 $7.50M -- -- -- --
Deferred Revenue (Current) $0 $650K -- $9.16M $17.10M $20.62M
Other Current Liabilities $164K $23K $85K $119K $26K $380K
Total Current Liabilities $11.23M $17.21M $14.21M $21.50M $27.19M $28.33M
Deferred Revenue (Non-Current) -- -- -- -- $7.68M $35.14M
Other Non-Current Liabilities $870K $0 $950K -- -- --
Total Non-Current Liabilities $8.60M $239K $8.13M $3.79M $12.81M $35.14M
Total Liabilities $19.84M $17.45M $22.34M $25.29M $40.00M $63.47M
Total Debt (incl. Leases) $2.98M $15.02M $10.74M $5.69M $6.99M $186K
Common Stock -- $48K $48K $36K $36K $3.0K
Retained Earnings -$230.1M -$179.9M -$282.4M -$214.2M -$145.5M -$111.3M
Accumulated Other Comp. Income $87K -$1.79M -$48K -$763K -- --
Total Stockholders' Equity $133.1M -$160.6M -$126.1M $147.0M $207.9M -$101.0M
Total Equity $133.1M -$160.6M -$126.1M $147.0M $207.9M -$101.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $84.85M $94.68M $76.05M $94.53M $103.2M $58.29M $36.76M $12.12M
Short-Term Investments $41.74M $41.48M $41.16M $40.82M $39.42M $37.35M $77.29M $0
Cash & Short-Term Investments $126.6M $136.2M $117.2M $135.3M $142.6M $95.64M $114.1M $12.12M
Total Current Assets $130.6M $141.1M $122.0M $140.3M $147.5M $99.01M $117.0M $12.47M
Property, Plant & Equipment, Net -- -- -- $0 $1.0K $419K $506K $8.0K
Other Non-Current Assets -- -- -- $4.88M $4.95M -- -- $1.02M
Total Non-Current Assets $11.94M $10.93M $14.68M $12.69M $13.35M $27.15M $13.84M $3.45M
Total Assets $142.5M $152.0M $136.7M $153.0M $160.9M $126.2M $130.8M $15.92M
Accounts Payable $931K $977K $568K $1.44M $2.08M $512K $805K $5.29M
Short-Term Debt -- -- -- $0 $0 -- -- $7.50M
Deferred Revenue (Current) -- -- -- $0 $0 -- -- $650K
Other Current Liabilities $268K $250K $316K $164K -- $39K $140K $23K
Total Current Liabilities $8.07M $6.57M $6.63M $11.23M $11.14M $7.32M $8.79M $17.21M
Other Non-Current Liabilities $848K $838K $881K $870K $1.11M $1.09M $1.08M $0
Total Non-Current Liabilities $6.33M $3.40M $6.72M $8.60M $9.90M $2.94M $3.79M $239K
Total Liabilities $14.40M $9.97M $13.36M $19.84M $21.05M $10.26M $12.59M $17.45M
Total Debt (incl. Leases) $1.31M $1.91M $2.42M $2.98M $3.44M $5.68M $6.61M $15.02M
Common Stock -- -- -- -- -- $48K $48K $48K
Retained Earnings -$266.5M -$250.8M -$240.7M -$230.1M -$223.1M -$343.0M -$340.2M -$179.9M
Accumulated Other Comp. Income -$170K -$51K -$17K $87K $94K $65K $99K -$1.79M
Total Stockholders' Equity $128.1M $142.1M $123.3M $133.1M $139.8M -$180.4M -$169.6M -$160.6M
Total Equity $128.1M $142.1M $123.3M $133.1M $139.8M -$180.4M -$169.6M -$160.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$45.35M -$36.57M -$68.17M -$68.77M -$34.12M -$44.26M
Depreciation & Amortization $400K $1.10M $1.02M $751K $544K $300K
Stock-Based Compensation $15.39M $0 $7.63M $7.53M $5.18M $1.80M
Change in Payables -$2.82M -$523K -$2.87M -$291K $361K $519K
Operating Cash Flow -$47.84M -$21.32M -$79.74M -$74.11M -$60.25M -$37.83M
Capital Expenditure -- -- -$414K -$1.43M -$1.76M -$766K
Free Cash Flow -- -- -$80.16M -$75.54M -$62.01M -$38.59M
Purchases of Investments -$10.40M $0 -$90.05M -$216.3M -- --
Investing Cash Flow -$5.81M $11.12M $64.14M -$99.28M -$1.76M $2.92M
Common Stock Issued -- -- $37.42M -- -- --
Share Repurchases -- -- -$663K -- -- --
Financing Cash Flow $135.5M $6.91M $75.98M $1.09M $131.7M $116.2M
Net Change in Cash $82.41M -$3.20M $60.38M -$172.3M $69.73M $81.28M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$15.62M -$10.18M -$10.62M -$6.91M -$24.78M -$7.58M -$6.08M -$4.81M
Depreciation & Amortization $0 $0 $0 $393K $2.0K $2.0K $2.0K $89K
Stock-Based Compensation $1.67M $911K $876K $51K $15.28M $0 $57K $0
Change in Payables -$192K $409K -$871K -$641K -$3.14M -$464K $1.43M $1.71M
Operating Cash Flow -$9.52M -$9.07M -$14.80M -$7.22M -$21.50M -$11.90M -$7.23M -$3.48M
Purchases of Investments -$5.67M -$8.00M -$10.94M -$8.91M -$1.49M $0 $0 $0
Investing Cash Flow -$385K -$346K -$440K -$1.36M -$4.45M $0 $0 $103K
Financing Cash Flow $82K $28.05M -$3.24M $0 $122.4M $13.02M $27K --
Net Change in Cash -$9.82M $18.63M -$18.48M -$8.63M $97.14M $1.10M -$7.20M -$5.80M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -6056.4% -1057.1% -823.3% -454.0% -110.2% -484.2%
Net Profit Margin -5668.6% -1044.8% -744.2% -440.3% -110.1% -481.4%
Return on Equity (ROE) -34.1% -- -- -46.8% -16.4% --
Return on Assets (ROA) -29.6% -229.7% -35.5% -39.9% -13.8% -26.3%
Current Ratio 12.49x 0.72x 12.58x 7.44x 8.70x 5.86x
Quick Ratio 12.05x 0.70x 12.35x 7.30x 8.54x 5.74x
Debt to Equity 0.02x -- -- 0.04x 0.03x --
Revenue Growth (YoY) -77.1% -61.8% -41.3% -49.6% +237.0% --
5Y Revenue / Share Growth -95.1% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -6056.4% -- -- -- --
Net Profit Margin -- -- -- -5668.6% -- -- -- --
Return on Equity (ROE) -33.8% -36.9% -40.5% -34.1% -30.9% -- -- --
Return on Assets (ROA) -30.4% -34.5% -36.5% -29.6% -26.9% -17.2% -15.5% -229.7%
Current Ratio 16.17x 21.47x 18.39x 12.49x 13.24x 13.52x 13.31x 0.72x
Quick Ratio 15.68x 20.72x 17.67x 12.05x 12.79x 13.06x 12.97x 0.70x
Debt to Equity 0.01x 0.01x 0.02x 0.02x 0.02x -- -- --
Revenue Growth (YoY) -- -- -- -- -100.0% -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -265.8% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001835579) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:00 UTC · Open in terminal